Technical Analysis for RARX - Ra Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 20.5 2.30% 0.46
RARX closed up 2.3 percent on Thursday, January 17, 2019, on 32 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical RARX trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Support Bullish 0.00%
Jan 17 Multiple of Ten Bullish Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 16 Multiple of Ten Bullish Other 2.30%
Jan 16 Wide Bands Range Expansion 2.30%
Jan 15 20 DMA Support Bullish 4.54%
Jan 15 Hammer Candlestick Bullish 4.54%
Jan 15 1,2,3 Pullback Bullish Bullish Swing Setup 4.54%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.54%

Older signals for RARX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its peptide chemistry platform delivers enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. The company's lead product candidate is RA101495, an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). It also develops Factor D inhibition for age-related macular degeneration and geographic atrophy; Oral C5 inhibitor for refractory generalized myasthenia gravis, lupus nephritis, and central nervous system (CNS) diseases; C1s inhibition for autoimmune/CNS diseases. The company has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
Is RARX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.9
52 Week Low 4.78
Average Volume 564,568
200-Day Moving Average 12.1001
50-Day Moving Average 16.8612
20-Day Moving Average 19.523
10-Day Moving Average 20.886
Average True Range 1.6101
ADX 34.21
+DI 25.8157
-DI 16.2453
Chandelier Exit (Long, 3 ATRs ) 19.0697
Chandelier Exit (Short, 3 ATRs ) 20.0603
Upper Bollinger Band 23.9044
Lower Bollinger Band 15.1416
Percent B (%b) 0.61
BandWidth 44.884495
MACD Line 1.014
MACD Signal Line 1.2146
MACD Histogram -0.2006
Fundamentals Value
Market Cap 463.48 Million
Num Shares 22.6 Million
EPS -2.84
Price-to-Earnings (P/E) Ratio -7.22
Price-to-Sales 0.00
Price-to-Book 3.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.11
Resistance 3 (R3) 21.95 21.26 21.84
Resistance 2 (R2) 21.26 20.85 21.34 21.75
Resistance 1 (R1) 20.88 20.60 21.07 21.04 21.66
Pivot Point 20.19 20.19 20.29 20.27 20.19
Support 1 (S1) 19.81 19.78 20.00 19.97 19.34
Support 2 (S2) 19.12 19.53 19.20 19.25
Support 3 (S3) 18.74 19.12 19.16
Support 4 (S4) 18.90